Cardiac resynchronization therapy in congenital heart disease
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články, přehledy
PubMed
27225165
DOI
10.1007/s00399-016-0433-7
PII: 10.1007/s00399-016-0433-7
Knihovny.cz E-zdroje
- Klíčová slova
- Biventricular pacemakers, artificial, Cardiomyopathy, Dyssynchrony, Heart failure, Prognosis,
- MeSH
- dospělí MeSH
- dysfunkce levé srdeční komory komplikace diagnóza prevence a kontrola MeSH
- lidé MeSH
- medicína založená na důkazech MeSH
- srdeční resynchronizační terapie metody MeSH
- srdeční selhání komplikace diagnóza prevence a kontrola MeSH
- vrozené srdeční vady komplikace diagnóza terapie MeSH
- výsledek terapie MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Cardiac resynchronization therapy (CRT) is an established treatment option for adult patients suffering heart failure due to idiopathic or ischemic cardiomyopathy associated with electromechanical dyssynchrony. There is limited evidence suggesting similar efficacy of CRT in patients with congenital heart disease (CHD). Due to the heterogeneity of structural and functional substrates, CRT implantation techniques are different with a thoracotomy or hybrid approach prevailing. Efficacy of CRT in CHD seems to depend on the anatomy of the systemic ventricle with best results achieved in systemic left ventricular patients upgraded to CRT from conventional pacing. Indications for CRT in patients with CHD were recently summarized in the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS) Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease and are presented in the text.
Zobrazit více v PubMed
Herzschrittmacherther Elektrophysiol. 2014 Sep;25(3):183-7 PubMed
Heart Rhythm. 2014 Dec;11(12 ):2303-5 PubMed
J Cardiovasc Electrophysiol. 2006 Oct;17(10):1068-71 PubMed
Circulation. 2003 May 13;107(18):2287-9 PubMed
Am Heart J. 2012 Apr;163(4):697-704 PubMed
Circulation. 2013 Feb 5;127(5):613-23 PubMed
J Am Coll Cardiol. 2008 Jan 1;51(1):12-7 PubMed
J Am Coll Cardiol. 2004 Nov 2;44(9):1927-31 PubMed
Europace. 2006 Apr;8(4):267-72 PubMed
Int J Cardiol. 2006 May 10;109 (2):160-8 PubMed
Europace. 2009 Feb;11(2):184-90 PubMed
Circulation. 2014 Nov 25;130(22):e186-90 PubMed
J Cardiovasc Electrophysiol. 2016 Feb;27(2):210-6 PubMed
Heart Rhythm. 2013 May;10(5):676-82 PubMed
Eur Heart J. 2013 Aug;34(29):2281-329 PubMed
Europace. 2006 Jul;8(7):530-6 PubMed
J Am Coll Cardiol. 2005 Dec 20;46(12):2277-83 PubMed
J Cardiovasc Electrophysiol. 2004 Apr;15(4):470-4 PubMed
Am J Cardiol. 2001 Jul 15;88(2):145-52 PubMed
Pacing Clin Electrophysiol. 2008 Feb;31 Suppl 1:S21-3 PubMed
J Cardiovasc Electrophysiol. 2009 Jan;20(1):58-65 PubMed
Circulation. 2008 May 20;117(20):2608-16 PubMed
Heart Rhythm. 2014 Oct;11(10):e102-65 PubMed
Heart Rhythm. 2008 Oct;5(10):1464-72 PubMed
Circulation. 2013 Feb 26;127(8):873-81 PubMed
Heart Rhythm. 2006 Nov;3(11):1285-92 PubMed
Circulation. 2011 Dec 20;124(25):2874-81 PubMed
Circulation. 2011 Mar 15;123(10 ):1061-72 PubMed
J Am Coll Cardiol. 2013 Jan 22;61(3):e6-75 PubMed
Heart Rhythm. 2009 Nov;6(11):1660-5 PubMed
Heart. 2009 Jul;95(14):1165-71 PubMed
Heart Rhythm. 2010 Mar;7(3):344-50 PubMed
Circulation. 2014 May 6;129(18):1879-91 PubMed
Pacing Clin Electrophysiol. 2009 May;32(5):683-7 PubMed
